GLOBUS MEDICAL INC - 8-K Filing
Globus Medical's stockholders approved an amendment to increase the share reserve under its 2021 Equity Incentive Plan from 11 million to 12 million shares on June 3, 2026. At the same meeting, two directors were elected with over 90% of votes for each candidate; Deloitte & Touche LLP was ratified as auditors with nearly unanimous support (over 99%), and stockholders approved executive compensation in a non-binding advisory vote. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)
Tickers: $GMED